Benzamide derivatives as p-38 kinase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 13, 2010
Grant Date -
May 17, 2007
app pub date -
Jul 23, 2004
filing date -
Jul 25, 2003
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Benzamide combounds of Formula I:and their compositions for modulating the activity of p38 kinases are provided, including p38α, and p38β kinase. Methods for treating, preventing or ameliorating one or more symptoms of a p38 kinase mediated disease or disorder such as inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, angiogenic disorders, infectious diseases, neurodegenerative diseases, and viral diseases are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully